{"name":"Ferrer Internacional S.A.","slug":"ferrer-internacional-sa","ticker":"","exchange":"","domain":"ferrerinternacionalsa.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"immunology","drugs":[{"name":"Furosemide-IR","genericName":"Furosemide-IR","slug":"furosemide-ir","indication":"Other","status":"marketed"},{"name":"Torasemide Prolonged Release","genericName":"Torasemide Prolonged Release","slug":"torasemide-prolonged-release","indication":"Other","status":"marketed"},{"name":"retapamulin 1% ointment","genericName":"retapamulin 1% ointment","slug":"retapamulin-1-ointment","indication":"Other","status":"marketed"},{"name":"torasemide-IR","genericName":"torasemide-IR","slug":"torasemide-ir","indication":"Other","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"cardiovascular","drugs":[{"name":"GF-001001-00","genericName":"GF-001001-00","slug":"gf-001001-00","indication":"Chronic hepatitis C","status":"phase_2"},{"name":"ozenoxacin 1% cream","genericName":"ozenoxacin 1% cream","slug":"ozenoxacin-1-cream","indication":"Treatment of impetigo caused by susceptible bacteria","status":"phase_3"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"FNP-223","genericName":"FNP-223","slug":"fnp-223","indication":"Relapsing forms of multiple sclerosis","status":"phase_2"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"torasemide-PR","genericName":"torasemide-PR","slug":"torasemide-pr","indication":"Edema associated with congestive heart failure","status":"marketed"}]}],"pipeline":[{"name":"FNP-223","genericName":"FNP-223","slug":"fnp-223","phase":"phase_2","mechanism":"FNP-223 is a small molecule that targets the S1P1 receptor.","indications":["Relapsing forms of multiple sclerosis"],"catalyst":""},{"name":"Furosemide-IR","genericName":"Furosemide-IR","slug":"furosemide-ir","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"GF-001001-00","genericName":"GF-001001-00","slug":"gf-001001-00","phase":"phase_2","mechanism":"GF-001001-00 is a small molecule that targets the HCV NS5A protein.","indications":["Chronic hepatitis C","Hepatitis C virus infection"],"catalyst":""},{"name":"Torasemide Prolonged Release","genericName":"Torasemide Prolonged Release","slug":"torasemide-prolonged-release","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ozenoxacin 1% cream","genericName":"ozenoxacin 1% cream","slug":"ozenoxacin-1-cream","phase":"phase_3","mechanism":"Ozenoxacin is a quinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV.","indications":["Treatment of impetigo caused by susceptible bacteria"],"catalyst":""},{"name":"retapamulin 1% ointment","genericName":"retapamulin 1% ointment","slug":"retapamulin-1-ointment","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"torasemide-IR","genericName":"torasemide-IR","slug":"torasemide-ir","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"torasemide-PR","genericName":"torasemide-PR","slug":"torasemide-pr","phase":"marketed","mechanism":"Torasemide is a loop diuretic that inhibits sodium and chloride reabsorption in the ascending limb of the loop of Henle, promoting urinary excretion of water and electrolytes.","indications":["Edema associated with congestive heart failure","Edema associated with hepatic cirrhosis","Edema associated with renal disease","Hypertension"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":8,"phaseCounts":{"phase_2":2,"marketed":5,"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}